Zonagen, Inc. (Nasdaq:ZONA)(PCX:ZONA), a biopharmaceutical company focused on the development of new drugs to treat hormonal and reproductive system disorders, today announced that the Company has...
Zonagen, Inc. (Nasdaq:ZONA)(PCX:ZONA) today reported financial results for the three-month and nine-month periods ended September 30, 2005 and provided an update on its clinical...
Zonagen, Inc. (NASDAQ:ZONA) announced today that the Company's President and CEO, Joseph Podolski, will present a corporate overview on Wednesday, November 9, 2005 at 10:10 a.m. Eastern Time (7:10...
-Zonagen, Inc. (Nasdaq:ZONA) (PCX:ZONA) today announced that the Company has awarded contracts for its next planned US studies for both Proellex(TM) and Androxal(TM). Pending review by the FDA...
Zonagen, Inc. (NasdaqSC: ZONA) will present at the following forum: ? What: Informed Investors Biotechnology / Healthcare / Pharmaceutical Investor Forum ? When: June 15, 2005 @ 2:35 PM Eastern...
Zonagen, Inc. (Nasdaq:ZONA)(PCX:ZONA) today provided an overview of the status of its Progenta(TM) and Androxal(TM) clinical programs, reported first quarter financial results for the...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.